SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-23-000011
Filing Date
2023-01-05
Accepted
2023-01-05 17:03:45
Documents
1
Period of Report
2023-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167295619781599.html 4  
1 FORM 4 wf-form4_167295619781599.xml 4 3287
  Complete submission text file 0001385508-23-000011.txt   4828
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1640 MARENGO STREET LOS ANGELES CA 90033
Business Address
O'Toole David D (Reporting) CIK: 0001491140 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 23512331